Researchers discovered a weak spot in harmful cells that act like zombies. These cells are called senescent cells. They survive by making lots of a protective protein that stops them from dying.
By taking away that protection, the cells kill themselves. This could become a new way to treat cancer and some age‑related illnesses.
Why Zombie‑Like Cells Are a Problem
Cancer starts when cells divide too fast. Tumors often contain senescent cells too. These cells no longer divide, but they stay active and cause trouble.
Chemo drugs can increase the number of senescent cells because they stop fast‑growing cells. The zombie cells do not make the tumor bigger directly, but they release harmful chemicals. Those chemicals can damage nearby tissue, help the cancer spread, and stir up a bad immune response. They are also linked to aging problems such as scar tissue.
Finding a Drug That Kills Zombie Cells
The team tested ten thousand different compounds on both healthy and senescent cells. They focused on a group called covalent compounds. These molecules can stick permanently to a target protein, making it possible to block proteins that were once “undruggable.”
From the large test, four promising compounds emerged. Three of them attacked the same protein, GPX4.
GPX4 and Ferroptosis: The Key to Self‑Destruction
GPX4 protects cells from a special kind of death called ferroptosis. Ferroptosis happens when iron and harmful oxygen molecules build up inside a cell.
Senescent cells produce too much GPX4, like taking painkillers while running on a hurt ankle. The damage stays, but the pain is hidden.
When the researchers blocked GPX4, the protective shield disappeared. Without it, ferroptosis could not be stopped, and the zombie cells died.
Good Results in Mouse Cancer Tests
The scientists tried the new drugs in three mouse cancer models. In each case, tumors got smaller and the mice lived longer.
These findings suggest that adding senolytic drugs to existing chemo or immunotherapy could help patients fight cancer better.
Experts say the approach could also help with other age‑related diseases, because senescent cells are involved in many health problems.